LA | |
---|---|
Post | - |
Pre | - |
M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | - | - | - | - | - | 24.0 | 35.5 | 0.5 | - | - | 60.0 |
1 | - | - | - | - | - | 240.5 | 409.0 | 1.5 | 2.5 | - | 653.5 |
LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
---|---|---|---|---|---|---|---|---|
Post | - | - | - | - | - | - | - | - |
Pre | - | - | - | - | - | - | - | - |
AME | |
---|---|
0 | - |
1 | - |
LOP1 | LOP2 | LOP3 | LOP4 | Total | |
---|---|---|---|---|---|
Post | - | - | - | - | - |
Pre | - | - | - | - | - |
central brain | |
---|---|
0 | 3.5 |
1 | 3.0 |
Number of post synapses: | 120 |
Number of pre synapses: | 1307 |
Number of output connections: | 5554 |
Coverage factor: | 1.1 |
Columnar completeness: | 0.21 |
Area completeness: | 0.37 |
Cell size (columns): | 102 |
Number of post synapses: | 0 |
Number of pre synapses: | 0 |
Number of output connections: | 0 |
Coverage factor: | 0 |
Columnar completeness: | 0 |
Area completeness: | 0 |
Cell size (columns): | 0 |
Number of post synapses: | 0 |
Number of pre synapses: | 0 |
Number of output connections: | 0 |
Coverage factor: | 0 |
Columnar completeness: | 0 |
Area completeness: | 0 |
Cell size (columns): | 0 |
instance | NT | total connections | connections /#MeVPMe10 (L) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | MeTu2a (R) | ACh | 35 | 17.5 | 30.4% | 30.4% |
1 | MeTu3b (R) | ACh | 27 | 13.5 | 23.5% | 53.9% |
2 | MeTu2b (R) | unclear | 10 | 5.0 | 8.7% | 62.6% |
3 | R7d (R) | His | 7 | 3.5 | 6.1% | 68.7% |
4 | Cm14 (R) | GABA | 5 | 2.5 | 4.3% | 73.0% |
5 | Dm-DRA1 (R) | Glu | 5 | 2.5 | 4.3% | 77.4% |
6 | MeTu3a (R) | ACh | 5 | 2.5 | 4.3% | 81.7% |
7 | Cm22 (R) | GABA | 4 | 2.0 | 3.5% | 85.2% |
8 | Cm28 (R) | unclear | 3 | 1.5 | 2.6% | 87.8% |
9 | Cm33 (R) | GABA | 2 | 1.0 | 1.7% | 89.6% |
10 | MeVPMe8 (R) | Glu | 2 | 1.0 | 1.7% | 91.3% |
instance | NT | total connections | connections /#MeVPMe10 (L) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | MeTu3b (R) | ACh | 1,691 | 845.5 | 30.6% | 30.6% |
1 | MeTu3a (R) | ACh | 1,114 | 557.0 | 20.1% | 50.7% |
2 | Cm22 (R) | GABA | 722 | 361.0 | 13.0% | 63.7% |
3 | Cm20 (R) | GABA | 633 | 316.5 | 11.4% | 75.2% |
4 | MeTu2b (R) | unclear | 403 | 201.5 | 7.3% | 82.4% |
5 | Cm14 (R) | GABA | 269 | 134.5 | 4.9% | 87.3% |
6 | Cm21 (R) | GABA | 176 | 88.0 | 3.2% | 90.5% |
7 | Cm10 (R) | GABA | 86 | 43.0 | 1.6% | 92.0% |
8 | MeVP39 (R) | unclear | 84 | 42.0 | 1.5% | 93.6% |
9 | Pm13 (R) | Glu | 57 | 28.5 | 1.0% | 94.6% |
10 | Mi14 (R) | Glu | 49 | 24.5 | 0.9% | 95.5% |
11 | MeLo5 (R) | ACh | 27 | 13.5 | 0.5% | 96.0% |
12 | MeTu3c (R) | ACh | 27 | 13.5 | 0.5% | 96.4% |
13 | MeVP31 (R) | ACh | 19 | 9.5 | 0.3% | 96.8% |
14 | Cm25 (R) | Glu | 18 | 9.0 | 0.3% | 97.1% |
15 | Cm28 (R) | unclear | 17 | 8.5 | 0.3% | 97.4% |
16 | aMe5 (R) | ACh | 12 | 6.0 | 0.2% | 97.6% |
17 | MeTu2a (R) | ACh | 12 | 6.0 | 0.2% | 97.9% |
18 | MeVP29 (R) | ACh | 12 | 6.0 | 0.2% | 98.1% |
19 | Cm16 (R) | Glu | 11 | 5.5 | 0.2% | 98.3% |
20 | Pm4 (R) | GABA | 10 | 5.0 | 0.2% | 98.4% |
21 | Cm3 (R) | GABA | 9 | 4.5 | 0.2% | 98.6% |
22 | Cm8 (R) | GABA | 8 | 4.0 | 0.1% | 98.8% |
23 | TmY10 (R) | ACh | 7 | 3.5 | 0.1% | 98.9% |
24 | Dm-DRA1 (R) | Glu | 6 | 3.0 | 0.1% | 99.0% |
25 | Dm20 (R) | Glu | 5 | 2.5 | 0.1% | 99.1% |
26 | aMe17a (R) | Glu | 4 | 2.0 | 0.1% | 99.2% |
27 | Lawf2 (R) | ACh | 4 | 2.0 | 0.1% | 99.2% |
28 | MeVP15 (R) | ACh | 4 | 2.0 | 0.1% | 99.3% |
29 | Tm_unclear (R) | GABA | 4 | 2.0 | 0.1% | 99.4% |
30 | Cm18 (R) | Glu | 3 | 1.5 | 0.1% | 99.4% |
31 | Dm8b (R) | Glu | 3 | 1.5 | 0.1% | 99.5% |
32 | aMe4 (R) | ACh | 2 | 1.0 | 0.0% | 99.5% |
33 | aMe9 (R) | ACh | 2 | 1.0 | 0.0% | 99.5% |
34 | Cm-DRA (R) | ACh | 2 | 1.0 | 0.0% | 99.6% |
35 | Cm7 (R) | Glu | 2 | 1.0 | 0.0% | 99.6% |
36 | MeVC27 (L) | unclear | 2 | 1.0 | 0.0% | 99.7% |
37 | Mi15 (R) | ACh | 2 | 1.0 | 0.0% | 99.7% |
38 | T2 (R) | ACh | 2 | 1.0 | 0.0% | 99.7% |
39 | Tm35 (R) | Glu | 2 | 1.0 | 0.0% | 99.8% |